Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
New research center created by leading blood and marrow transplant organizations

New research center created by leading blood and marrow transplant organizations

Bone marrow and stem cell transplantation rejection averted by UV light exposure

Bone marrow and stem cell transplantation rejection averted by UV light exposure

West Nile treatment showing 100% response rate among immunocompetent patients

West Nile treatment showing 100% response rate among immunocompetent patients

Study sheds new light on children with a severe form of acute lymphoblastic leukemia

Study sheds new light on children with a severe form of acute lymphoblastic leukemia

World's first gene therapy trial aimed at preventing cancer

World's first gene therapy trial aimed at preventing cancer

Embryo testing could produce babies who might aid sick siblings

Embryo testing could produce babies who might aid sick siblings

Bush on healthcare

Bush on healthcare

Developing smart drugs

Developing smart drugs

Transplanted bone-marrow cells could regenerate nerve cells in the brain

Transplanted bone-marrow cells could regenerate nerve cells in the brain

AGT Biosciences Limited and ChemGenex Therapeutics today announced merger agreement

AGT Biosciences Limited and ChemGenex Therapeutics today announced merger agreement

FDA approval for Cladribine to treat active Hairy Cell Leukemia

FDA approval for Cladribine to treat active Hairy Cell Leukemia

New gene presents a potent new target for breast cancer therapy

New gene presents a potent new target for breast cancer therapy

Drug duo prevents life-threatening condition in children undergoing stem cell transplant

Drug duo prevents life-threatening condition in children undergoing stem cell transplant

Green tea helps kill cells of the most common leukemia

Green tea helps kill cells of the most common leukemia

Molecular analyses of leukemia patients suggest strategies for better treatments

Molecular analyses of leukemia patients suggest strategies for better treatments

New method to induce embryonic stem cells to develop into bone marrow and blood cells

New method to induce embryonic stem cells to develop into bone marrow and blood cells

New center enables genetic treatments and advances

New center enables genetic treatments and advances

Compounds that may stop replication of T-cell leukemia virus

Compounds that may stop replication of T-cell leukemia virus

First North American sales of Raycell X-ray blood irradiator

First North American sales of Raycell X-ray blood irradiator

St. John’s wort may interfere with cancer-fighting drug’s ability to prevent relapse in leukemia patients

St. John’s wort may interfere with cancer-fighting drug’s ability to prevent relapse in leukemia patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.